Trials / Conditions / Stage IIB Cervical Cancer

Stage IIB Cervical Cancer

20 registered clinical trials studyying Stage IIB Cervical Cancer.

Status	Trial	Sponsor	Phase
Unknown	Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer NCT03469531	Zhujiang Hospital	Phase 2
Completed	Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	N/A
Terminated	MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer NCT01992861	University of Washington	—
Completed	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520	City of Hope Medical Center	N/A
Completed	Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer NCT01764802	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa NCT01098630	Gynecologic Oncology Group	—
Withdrawn	Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT01019278	Abramson Cancer Center at Penn Medicine	Phase 2
Completed	Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer NCT00941070	National Cancer Institute (NCI)	Phase 2
Terminated	Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extr NCT00577317	Gynecologic Oncology Group	Phase 3
Completed	FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer NCT00559377	National Cancer Institute (NCI)	Phase 2
Completed	Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer NCT00054444	Gynecologic Oncology Group	Phase 1
Completed	Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Th NCT00416455	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S NCT00460356	Gynecologic Oncology Group	—
Terminated	Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer NCT00262821	National Cancer Institute (NCI)	Phase 3
Completed	EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometria NCT00107445	National Cancer Institute (NCI)	Phase 2
Completed	Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT00104910	Gynecologic Oncology Group	Phase 1
Completed	Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer NCT00068549	Gynecologic Oncology Group	Phase 1
Completed	Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Ane NCT00017004	Gynecologic Oncology Group	Phase 3
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—
Withdrawn	Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or NCT01313104	Northwestern University	N/A